Growth Metrics

Vycor Medical (VYCO) Free Cash Flow (2016 - 2025)

Vycor Medical has reported Free Cash Flow over the past 16 years, most recently at $37627.0 for Q4 2025.

  • Quarterly Free Cash Flow rose 198.3% to $37627.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$15077.0 through Dec 2025, down 125.08% year-over-year, with the annual reading at -$18695.0 for FY2025, 134.15% down from the prior year.
  • Free Cash Flow was $37627.0 for Q4 2025 at Vycor Medical, up from -$72428.0 in the prior quarter.
  • Over five years, Free Cash Flow peaked at $86034.0 in Q2 2024 and troughed at -$78780.0 in Q1 2022.
  • The 5-year median for Free Cash Flow is -$7629.5 (2023), against an average of -$8252.2.
  • The largest YoY upside for Free Cash Flow was 507.41% in 2024 against a maximum downside of 9566.41% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at $31768.0 in 2021, then plummeted by 203.98% to -$33032.0 in 2022, then soared by 98.8% to -$396.0 in 2023, then plummeted by 9566.41% to -$38279.0 in 2024, then skyrocketed by 198.3% to $37627.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Free Cash Flow are $37627.0 (Q4 2025), -$72428.0 (Q3 2025), and $46633.0 (Q2 2025).